Position in HALO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$340,317
+$129,803 QoQ
Shares Held
4,348
+39.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#425
of 647 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AlphaGrep UK Ltd holds $6,410,302 across 17 Biotechnology names. HALO ranks #8 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,943 | $1,211,538 | |
| 2 | MRNA |
Moderna, Inc.
|
8,106 | $567,663 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,623 | $488,571 | |
| 4 | INCY |
Incyte Corp
|
4,295 | $486,881 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
12,745 | $451,045 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
4,599 | $374,864 | |
| 7 | ERAS |
Erasca, Inc.
|
20,340 | $372,628 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
This page
|
4,348 | $340,317 |
All Filings in HALO
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $340,317 | 4,348 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $210,514 | 3,128 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||